Hormone Replacement Therapy for Women: A Midlife Guide

Let's be honest about why this topic makes people nervous.

A lot of women were told, somewhere along the way, that hormone therapy causes cancer, full stop. Maybe your mom stopped hers overnight in 2002. Maybe a doctor waved you off it without much of a conversation. So now you're symptomatic, you're curious, and you're also a little scared.

This guide is for women in midlife, in perimenopause or menopause, who are considering hormone replacement therapy (HRT). We'll explain what HRT is, who it helps, the real risks and benefits, and how treatment can be personalized, so you can make an informed decision about your own health.

Quick summary: what you need to know

• Hormone replacement therapy is used during perimenopause and menopause.
• Menopause hormone therapy replaces the estrogen lost after menopause, and systemic estrogen treats a wide range of menopause symptoms.
• Low-dose vaginal hormones target vaginal and urinary symptoms.
• Hormone therapy may lower the risk of osteoporosis.
• Risks include blood clots, stroke, and breast cancer. They are generally small and depend on the type of hormone, the route, timing, and your history.
• Breast cancer risk rises after about five years of estrogen plus a progestogen.
• Hormone therapy is generally safest for women under 60 or within 10 years of menopause.
• FDA-approved formulations are generally preferred over compounded hormones when they are available.

What is hormone replacement therapy?

Hormone therapy replaces the hormones your ovaries wind down as you move through perimenopause and menopause. For many women it works best as one part of a broader, personalized plan that also addresses sleep, metabolism, and overall health. Four hormones are involved.

Estrogen

Estrogen is the primary hormone used to relieve menopause symptoms such as hot flashes, night sweats, sleep disturbances, vaginal dryness, and bone loss.

Progesterone

In my experience, progesterone is often the most important first hormone for women in perimenopause. I like to think of progesterone as a woman's "calming" hormone. Symptoms of perimenopause often look like the opposite of calm, because progesterone is declining. Many women with new-onset anxiety, irritability, moodiness, edginess, or heavier periods feel better with the right form and dose of progesterone.

In conventional medicine, progesterone is used in menopause only if you have a uterus, to protect the uterine lining from estrogen. Women taking estrogen who still have a uterus need this protection to reduce the risk of endometrial cancer.

Testosterone

Yes, women need testosterone too. It is sometimes added, mainly for desire and, in some cases, for energy, mood, and body composition.

Which combination, for whom

• Estrogen plus a progestogen (combination therapy): women who have a uterus.
• Estrogen alone: women who no longer have a uterus.
• Progesterone alone: often the first step for women in perimenopause.

Whether you still have a uterus is one of the most important factors in deciding which type of HRT is right for you.

Who is HRT for?

Broadly, it's for women in perimenopause, early menopause, or after menopause whose symptoms are affecting daily life: the hot flashes, the 3 a.m. wake-ups, the brain fog, the mood swings, the vaginal dryness. After a real conversation with a clinician, they decide the benefits are worth it for them. The average age of menopause in the US is 51.

It's not a one-size-fits-all yes. Decisions depend on how severe your symptoms are, your medical history, and which options make sense for you. Certain histories, like a hormone-sensitive cancer or a history of blood clots, call for extra caution. That's the whole point: this is shared decision-making, not a blanket rule.

Is hormone replacement therapy for women safe?

This is the question under all the other questions, so let's take it head-on.

The breast cancer story (the honest version)

The fear traces back to the 2002 Women's Health Initiative study. Here's what got lost in the headlines:

• The arm that showed a small increase in breast cancer used estrogen plus a synthetic progestin (medroxyprogesterone), not bioidentical progesterone. Even there, the increase was small in absolute terms, on the order of one extra case per 1,000 women per year, with no increase in breast cancer deaths. That risk rises after about five years of combined therapy.
• The estrogen-only arm did not raise breast cancer risk, and was actually associated with less breast cancer.

The risk is small, and it depends heavily on the type of hormone. The synthetic progestin in that study isn't the bioidentical progesterone we use. Menopause hormone therapy has also been associated in some women with lower rates of type 2 diabetes and colorectal cancer. Stroke is one of the risks we discuss too. The science is still debated in places, and we stay honest about that, but the blanket "it causes cancer" message left out most of the story.

Blood clots, and why how you take it matters

You may have heard that estrogen raises the risk of blood clots. It can, but how you take it changes that a lot, and the word "doubles" gets used in a way that's genuinely misleading.

Blood clots are uncommon to begin with in this age group. Estrogen taken as a pill does raise that small baseline, very roughly from about 1 in 1,000 women a year to about 2 in 1,000. Still uncommon. Estrogen taken through the skin, as a patch or gel, doesn't meaningfully raise clot risk, because it skips the first pass through the liver. That's one big reason we often choose transdermal estrogen. The form of estrogen changes the risk.

Low-dose vaginal estrogen uses far less estrogen than systemic treatment. It treats vaginal and urinary symptoms, including dryness and painful intercourse, as a cream, tablet, ring, or troche.

The "timing window": a conversation, not a closed door

You'll hear that HRT is safest started before age 60 or within 10 years of your last period. That guideline is real and useful, and research suggests starting earlier may lower cardiovascular risk for some women. But I want to be clear about how we treat it: it's a starting point for a discussion, not a door that slams shut.

At AgeWell, we start women on hormone therapy at various stages after menopause, when it's the right fit, after a careful, shared conversation about the risks and benefits of being on versus off hormones at your particular age and stage. Your age doesn't make the decision. You and your provider do.

Types of HRT and how it's delivered

Most of these hormones come in many forms: pills, injections, creams and gels, patches, vaginal rings, vaginal troches, pellets, and more. Your needs decide which one we choose.

Systemic estrogen

Delivered as a pill, patch, gel, mist, cream, vaginal ring, troche, and more. Systemic estrogen reaches the whole body and treats the broad range of menopause symptoms.

Vaginal hormones

Low-dose estrogen, DHEA, or testosterone, delivered as a vaginal cream, tablet, ring, or troche. Very little is absorbed into the rest of the body, and it treats vaginal and urinary symptoms. Higher doses placed vaginally can treat the whole body, so we'll always tell you which kind you're using.

Progesterone

We often prefer oral bioidentical progesterone, because taken by mouth it can help with better sleep and a calmer mind. It is essential for women with a uterus who take estrogen.

Testosterone

Used off-label in women, as there is no FDA-approved female product yet. Forms include injections, creams, pellets, and more. Injections have been part of our care for women for many years.

DHEA

Taken by mouth or used vaginally, depending on your symptoms and labs.

Pellets

Pellet implants are another delivery route, with their own tradeoffs.

The right combination and route is part of what makes this personal. See all of your hormone therapy options.

Testosterone for women

Testosterone is a hormone women make and rely on too. The formal, evidence-based use is for low sexual desire that's causing distress and hasn't responded to estrogen and progesterone. In my clinical experience, I also see benefits beyond libido, including energy, mood, and body composition, in carefully selected and monitored patients, though the research there is still catching up. Because it's used off-label and compounded options vary, it calls for an experienced hand and careful monitoring.

Bioidentical vs. synthetic

"Bioidentical" means the hormone is molecularly identical to what your body makes. As you saw with progesterone above, the type of hormone can matter. Bioidentical hormones are available both as FDA-approved products from standard pharmacies and from compounding pharmacies; FDA-approved formulations are generally preferred when they fit your needs.

What to expect: monitoring and follow-up

Good hormone care isn't "prescribe and disappear." We start, then re-check how your symptoms respond, watch for side effects such as breast tenderness, use blood tests when appropriate, and adjust over time. The goal is the lowest effective approach that gets you feeling like yourself, reviewed regularly rather than set in stone, while helping protect bone health when that's indicated.

How we personalize it at AgeWell

We don't hand out a one-size protocol. We listen to your story, study your signals (hormones, metabolic markers, sleep, stress), and build a plan with you around your symptoms, medical history, and risk tolerance. That includes choosing the type and route of hormones, and whether you still have a uterus. Our approach is guided by the Menopause Society's framework for individualized decisions, and we adjust recommendations over time.

We favor bioidentical hormones, we choose the route to manage risk, and we make the decision together. Your age or how long it's been since your last period starts the conversation. It doesn't end it.

Our promise stays the same: you'll feel heard, understand your options, and know your next step, whether that's starting hormones, adjusting your plan, or simply getting answers. Learn more about hormone therapy for women, perimenopause and menopause care, and women's hormone health at AgeWell.

Already on hormone therapy, or thinking about changing providers? Get the free Hormone Care Quality Checklist: 15 questions to bring to your next visit.

Frequently asked questions

Is hormone therapy safe?

For most healthy women in midlife who have symptoms, the benefits can outweigh the risks, especially with a transdermal (through-the-skin) route. The risks are real but generally small, and they depend on the type, route, dose, timing, and your personal history. It's an individualized, shared decision. As the evidence has evolved, the FDA has also requested changes to some of the older risk warnings on hormone therapy labels.

Does HRT cause breast cancer?

In the major trial, estrogen alone did not raise breast cancer risk, and was associated with less of it. The small increase seen was with a synthetic progestin, not bioidentical progesterone: about one extra case per 1,000 women a year, depending partly on duration, with no increase in breast cancer deaths. The type of hormone matters.

Does HRT cause blood clots?

Estrogen in pill form modestly raises a low baseline clot risk, very roughly from 1 in 1,000 to 2 in 1,000 a year. Some systemic formulations can also raise stroke risk. Estrogen through the skin, as a patch or gel, doesn't meaningfully raise clot risk, which is why we often prefer it.

Is it too late to start HRT if I'm past 60 or years past menopause?

Not automatically. The "before 60 or within 10 years" guideline is a starting point for discussion, not a hard cutoff. We start women at various stages after menopause, when it's the right fit, after a careful risk-benefit conversation.

What's the difference between progesterone and progestins?

Both are progestogens, but progesterone is the bioidentical hormone your body makes, while progestins are synthetic, like those in many birth control pills. We use bioidentical progesterone.

Does HRT cause weight gain?

HRT itself isn't a reliable cause of weight gain. The midlife weight shift is mostly driven by changing metabolism, muscle loss, sleep, and stress. Many women find that managing their symptoms actually makes healthy habits easier.

This article is educational and not a substitute for personalized medical advice. AgeWell works alongside your primary care provider. Talk with a qualified clinician about your specific situation. If you have severe or urgent symptoms, seek emergency care.

Sources

• The Menopause Society (NAMS) 2022 Hormone Therapy Position Statement (PMID 35797481)
• Hormone Replacement Therapy, StatPearls (NCBI NBK493191)
• Critical review of WHI evidence on HRT and breast cancer (PMC10758198)
• Menopausal hormone therapy and breast cancer: evidence from randomized trials (PMC6386596)
• ACOG: Postmenopausal Estrogen Therapy, Route of Administration and Risk of VTE
• Comparative evidence: transdermal vs oral menopausal hormone therapy (NCBI NBK614933)
• Global Consensus Position Statement on Testosterone Therapy for Women (PMID 31488288)
• ISSWSH 2021 Clinical Practice Guideline: testosterone for HSDD (PMC8064950)